valsartan has been researched along with Apnea, Central in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borrelli, C; Emdin, M; Gentile, F; Giannoni, A; Passino, C; Sciarrone, P; Spiesshoefer, J; Vergaro, G | 1 |
| Callan, PD; Clark, AL | 1 |
1 review(s) available for valsartan and Apnea, Central
| Article | Year |
|---|---|
Heart failure - what's new and what's changed?
Topics: Aged; Aged, 80 and over; Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Diabetes Complications; Drug Combinations; Heart Failure; Humans; Positive-Pressure Respiration; Practice Guidelines as Topic; Sleep Apnea, Central; Tetrazoles; Valsartan | 2016 |
1 other study(ies) available for valsartan and Apnea, Central
| Article | Year |
|---|---|
Sacubitril-valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Drug Combinations; Heart Failure; Humans; Sleep Apnea, Central; Stroke Volume; Tetrazoles; Valsartan | 2021 |